Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Findings show that 81% of posts related to cancer on the social media platform TikTok touted fake cures. Most cancer cures ...

Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others ...

I share how faith, positive affirmations and resilience helped me overcome stage 2 colon cancer and find strength in recovery ...

(PV) treatment approaches include both therapeutic phlebotomy and medications like hydroxyurea or interferon to control blood counts, with treatment selection based on individual risk factors and ...

The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Subcutaneous Sarclisa, administered via OBDS, showed non-inferior efficacy to IV Sarclisa in relapsed/refractory multiple ...

Obtaining a second opinion during your cancer treatment can be a daunting but also life-changing step; however, surprisingly ...

Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling ...

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.